A bacterial model for expression of mutations in the human ornithine transcarbamylase (OTC) gene
- Univ. of Minnesota, Mineapolis (United States)
OTC is a mitochondrial enzyme catalyzing the formation of citrulline from carbamyl phosphate and ornithine. X-linked deficiency of OTC is the most prevalent genetic defect of ureagenesis. Mutations and polymorphisms in the OTC gene identified in deficient patients have indicated the occurrence of many family-specific, unique alleles. Due to the low frequency of recurrent mutations, distinguishing between deleterious mutations and polymorphisms is difficult. Using a human OTC gene containing plasmid driven by a tac promoter, we have devised a simple and efficient method for expressing mutations in the mature human OTC enzyme. To demonstrate this method, PCR engineered site-directed mutagenesis was employed to generated cDNA fragments which contained either the R151Q or R277W known mutations found in patients with neonatal and late-onset OTC deficiency, respectively. The normal allele for each mutation was also generated by an identical PCR procedure. Digestion with Bgl II- and Sty I-generated mutant and normal replacement cassettes containing the respective mutant and wild type sequences. Upon transformation of JM109 E.coli cells, OTC enzymatic activity was measured at log and stationary phases of growth using a radiochromatographic method. The R141Q mutation abolished enzymatic activity (<0.02% of normal), whereas the R277W mutation expressed partial activity (2.3% of normal). In addition, a PCR-generated mutation, A280V, resulted in 73% loss of catalytic activity. This OTC expression system is clinically applicable for distinguishing between mutations and polymorphisms, and it can be used to investigate the effects of mutations on various domains of the OTC gene.
- OSTI ID:
- 134757
- Report Number(s):
- CONF-941009-; ISSN 0002-9297; TRN: 95:005313-1496
- Journal Information:
- American Journal of Human Genetics, Vol. 55, Issue Suppl.3; Conference: 44. annual meeting of the American Society of Human Genetics, Montreal (Canada), 18-22 Oct 1994; Other Information: PBD: Sep 1994
- Country of Publication:
- United States
- Language:
- English
Similar Records
NEUROSPORA MUTANTS LACKING ORNITHINE TRANSCARBAMYLASE
Detection and functional characterization of the novel missense mutation Y254D in type II 3{beta}-hydroxysteroid dehydrogenase (3{beta}HSD) gene of a female patient with nonsalt-losing 3{beta}HSD deficiency
Related Subjects
BASIC STUDIES
GENE MUTATIONS
BIOLOGICAL MODELS
GENES
MUTATION FREQUENCY
ENZYMES
ENZYME ACTIVITY
UROGENITAL SYSTEM DISEASES
AGE DEPENDENCE
PATIENTS
HEREDITARY DISEASES
POLYMERASE CHAIN REACTION
EFFICIENCY
MITOCHONDRIA
ORNITHINE
HUMAN X CHROMOSOME
GENETICS
MUTAGENESIS
ESCHERICHIA COLI